Hikma Partners for Respiratory Combo DrugBy
Hikma Pharmaceuticals, an Amman, Jordan-based pharmaceutical company, has signed an exclusive licensing and distribution agreement with Orion Corporation, an Espoo, Finland-based pharmaceuticals and diagnostic tests developer, for Orion’s new inhaler product for a combination asthma regimen.
Under the agreement, Hikma has exclusive rights to register, distribute, market, and sell Orion’s Easyhaler combination product, a dry-powder inhaler of budesonide and formoterol for treating asthma and chronic obstructive pulmonary disease, in all of Hikma’s Middle East and North Africa markets. Hikma has local presence, sales, marketing capabilities, and regulatory expertise in these regions.
Source: Hikma Pharmaceuticals